Leadership Team

sv-lines-180x1200-purple-lavender

Through every shift, every emergency, and every patient, our team is with you. Always prepared. Always precise. Always protecting. 

Always Delivering.

Meet the Spectrum Vascular Team

Ken Miller-Updated

Ken Miller

Chief Executive Officer

Henry Burmeister-Updated

Henry Burmeister

Chief Financial Officer

Doug-Edited

Doug Shook

Chief Commercial Officer

Jackie Ferro

Jackie Ferro

SVP of Quality Assurance & Regulatory Affairs

Adam-EdelHauser-Editedv2

Adam Edelhauser

VP of R&D

Ken Miller

Chief Executive Officer

Ken Miller is a seasoned executive who brings over 35 years of leadership experience in the medical device industry to Spectrum Vascular.

Ken’s established ability to drive commercial and operational excellence across both growth-stage and established healthcare organizations has consistently delivered strong revenue growth.

Before joining Spectrum Vascular, Ken held CEO and senior executive leadership roles at multinational companies like Becton Dickinson & Company, and Novo Nordisk, where he built and led high-performing teams and expanded market presence.

Henry Burmeister-Updated

Henry Burmeister

Chief Financial Officer

Henry Burmeister brings a wealth of experience in medical devices and private equity, with a focus on financial leadership since 2012. He has served as CFO for several private equity-backed companies, most recently at Inventus Power, and previously at Corza Medical and Wytech Industries LLC. Prior to these roles, he held senior leadership positions at Viant Medical and Vention Medical.

Earlier in his career, Henry held a range of finance roles, including Operations Controller, FP&A Director, and Business Controller. Before transitioning into finance, he began his career as a Measurement & Quality Engineer/Team Lead at Buckeye Pipe Line Company.

Henry holds a BS in Chemical Engineering from Lafayette College and an MBA from Lehigh University. He also successfully passed the Chartered Financial Analyst exams from the CFA Institute and was a varsity football player during his time at Lafayette College.

Doug Shook

Chief Commercial Officer

Doug Shook brings more than two decades of commercial leadership experience in the medical technology space to his role, with deep expertise in driving go-to-market strategies and scaling customer engagement.

He joined Spectrum from ICU Medical, where he served as the Global Business Unit Leader for Vascular Access. Prior to ICU Medical, Doug Shook held commercial leadership roles at Smiths Medical, Access Scientific and CareFusion, manufacturers of premium vascular access devices for the acute and ambulatory care markets.

Doug holds a BS in Biomedical Engineering from Georgia Tech and an MBA from the University of Michigan, where he graduated Magna Cum Laude.

Jackie Ferro

Jackie Ferro

SVP of Quality Assurance & Regulatory Affairs

Jackie brings more than 34 years of transformational leadership experience across the medical device, diagnostics, pharmaceutical, biologics, and digital health industries. Throughout her career, she has served as a strategic business partner to executive teams, driving regulatory excellence, accelerating global market access, and building high-performance organizations that consistently deliver safe, compliant, and commercially successful products.


Over the course of her career, Jackie has worked across companies ranging from emerging innovators to multinational corporations, leading enterprise level regulatory and quality organizations, shaping global submission strategies, and remediating high-risk compliance situations with flawless execution. Her leadership has directly enabled new product introductions, protected global supply chains, and strengthened quality systems to withstand the most rigorous FDA, ISO, and international regulatory scrutiny.

Adam-EdelHauser-Editedv2

Adam Edelhauser

VP of R&D

Adam Edelhauser brings deep expertise in medical device innovation and product development. He joined Spectrum Vascular from Koru Medical Systems, where he was Director of R&D – New Product Development and Sustaining and spearheaded the design, development, and commercialization of cutting-edge infusion solutions delivering over 2 million infusions worldwide annually.

Prior to Koru, Adam was with Becton Dickinson for more than 8 years, where he took on successive roles of greater responsibility, culminating in his promotion to Associate R&D Director – New Product Development, overseeing the development of 14 products valued at over $300M. Earlier in his career, Adam was a Project Engineer at Stryker Orthopedics. Adam holds a BS in Mechanical Engineering from Rutgers University.